Analgesic action of acetaminophen in symptomatic osteoarthritis of the knee

Rheumatology

Volumn 45, Issue 6, 2006, Pages 765-770

  Shen, H ^a,b   Sprott, H ^a,b   Aeschlimann, A ^c   Gay, R E ^a,b   Michel, B A ^a,b   Gay, S ^a,b   Sprott, Haiko ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Reha Clinic   (Switzerland)

Author keywords

Acetaminophen; Beta endorphin; Osteoarthritis; Pain; Rofecoxib

Indexed keywords

BETA ENDORPHIN; KAPPA OPIATE RECEPTOR; MESSENGER RNA; PARACETAMOL; ROFECOXIB; SEROTONIN; SUBSTANCE P;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; MALE; PAIN ASSESSMENT; PATIENT SCHEDULING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTONIN BLOOD LEVEL; SYMPTOM; TREATMENT DURATION; VISUAL ANALOG SCALE;

ACETAMINOPHEN; AGED; AGED, 80 AND OVER; ANALGESICS, NON-NARCOTIC; BETA-ENDORPHIN; BIOLOGICAL MARKERS; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HUMANS; KNEE JOINT; LACTONES; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; SEROTONIN; SEVERITY OF ILLNESS INDEX; SUBSTANCE P; SULFONES; TREATMENT OUTCOME;

EID: 33745594314     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei253     Document Type: Article

References (32)

1. Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ 2003;81:646-56.
2. Buckwalter JA, Saltzman C, Brown T, Schurman DJ. The impact of osteoarthritis: Implications for research. Clin Orthop 2004; 427(Suppl.):S6-15.
3. Elders MJ. The increasing impact of arthritis on public health. J Rheumatol Suppl 2000;60:6-8.
4. Reginster JY. The prevalence and burden of arthritis. Rheumatology 2002;41(Suppl. 1):3-6.
5. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines: Recommendations for the medical management of osteoarthritis of the hip and knee. Arthritis Rheum 2000;43:1905-15.
6. Jordan KM, Arden NK, Doherty M et al. Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a task force of the standing committee for international clinical studies including therapeutic trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55.
7. Botting R. Paracetamol-inhibitable COX-2. J Physiol Pharmacol 2000;51:609-18.
8. Chandrasekharan NV, Dai H, Roos KL et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression. Proc Natl Acad Sci USA 2002;99:13926-31.
9. Takeba Y, Suzuki N, Kaneko A, Asai T, Sakane T. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 2001;28:2176-83.
10. Faletti AG, Mohn C, Farina M, Lomniczi A, Rettori V. Interaction among beta-endorphin, nitric oxide and prostaglandins during ovulation in rats. Reproduction 2003;125:469-77.
11. Schaible HG, Ebersberger A, Von Banchet GS. Mechanisms of pain in arthritis. Ann N Y Acad Sci 2002;966:343-54.
12. Levine JD, Clark R, Devor M, Helms C, Moskowitz MA, Basbaum AI. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984;226:547-9.
13. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 1987;235:893-5.
14. Shen H, Aeschlimann A, Reisch N et al. Kappa and delta opioid receptors are expressed but down-regulated in fibroblast-like synoviocytes of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 2005;52:1402-10.
15. Gaveriaux C, Peluso J, Simonin F, Laforet J, Kieffer B. Identification of kappa- and delta-opioid receptor transcripts in immune cells. FEBS Lett 1995;369:272-6.
16. Gunji N, Nagashima M, Asano G, Yoshino S. Expression of kappa-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis. Rheumatol Int 2000;19:95-100.
17. Raffa RB, Walker EA, Sterious SN. Opioid receptors and acetaminophen (paracetamol). Eur J Pharmacol 2004;503:209-10.
18. Altman R, Asch E, Bloch D et al. The American College of Rheumatology criteria for the classification and reporting osteoarthritis of the knee. Arthritis Rheum 1986;29:1039-49.
19. Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W, Theiler R. Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index. Z Rheumatol 1996;55:40-9.
20. Sprott H, Shen H, Gay S, Aeschlimann A. Acetaminophen may act through β endorphin. Ann Rheum Dis 2005;64:1522.
21. O'Connor TM, O'Connell J, O'Brien DI, Goode T, Bredin CP, Shanahan F. The role of substance P in inflammatory disease. J Cell Physiol 2004;201:167-80.
22. Inoue H, Shimoyama Y, Hirabayashi K et al. Production neuropeptide substance P by synovial fibroblasts from patients with rheumatoid arthritis and osteoarthritis. Neurosci Lett 2001; 303:149-52.
23. Nakao K, Nakai Y, Oki S, Horii K, Imura H. Presence of immuno-reactive beta-endorphin in normal human plasma: A concomitant release of beta-endorphin with adrenocorticotropin after metyrapone administration. J Clin Invest 1978;62:1395-8.
24. Mousa SA, Shakibaei M, Sitte N, Schafer M, Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004;145:1331
25. Stein C, Hassan AH, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4
26. Elvenes J, Andjelkov N, Figenschau Y, Seternes T, Bjorkoy G, Johansen O. Expression of functional mu-opioid receptors in human osteoarthritic cartilage and chondrocytes. Biochem Biophys Res Commun 2003;311:202-7.
27. Hartwig AC. Peripheral beta-endorphin and pain modulation. Anesth Prog 1991;38:75-8.
28. Likar R, Schafer M, Paulak F et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth Analg 1997;84:1313-7.
29. Hermanussen S, Do M, Cabot PJ. Reduction of beta-endorphincontaining immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: Reversible by donor activated lymphocytes. Anesth Analg 2004;98:723-9.
30. Rittner HL, Machelska H, Stein C. Leukocytes in the regulation of pain and analgesia. J Leukoc Biol 2005;78:1215-22.
31. Mousa SA, Zhang Q, Sitte N, Ji R, Stein C. Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001;115:71-8.
32. Jessell TM, Iversen LL. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature 1977;268:549-51.